0001157523-14-004352.txt : 20141104 0001157523-14-004352.hdr.sgml : 20141104 20141104162951 ACCESSION NUMBER: 0001157523-14-004352 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20141104 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20141104 DATE AS OF CHANGE: 20141104 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PHOTOMEDEX INC CENTRAL INDEX KEY: 0000711665 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 592058100 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-11635 FILM NUMBER: 141193569 BUSINESS ADDRESS: STREET 1: 100 LAKESIDE DRIVE STREET 2: SUITE 100 CITY: HORSHAM STATE: PA ZIP: 19044 BUSINESS PHONE: 2156193600 MAIL ADDRESS: STREET 1: 100 LAKESIDE DRIVE STREET 2: SUITE 100 CITY: HORSHAM STATE: PA ZIP: 19044 FORMER COMPANY: FORMER CONFORMED NAME: LASER PHOTONICS INC DATE OF NAME CHANGE: 19920703 8-K 1 a50976663.htm PHOTOMEDEX, INC. 8-K a50976663.htm




 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

_____________

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of report (Date of earliest event reported): November 4, 2014

PhotoMedex, Inc.
(Exact Name of Registrant Specified in Charter)
 
 
 
Nevada
0-11635
59-2058100
(State or Other
(Commission File
(I.R.S. Employer
Jurisdiction of
Number)
Identification No.)
Incorporation)
   
 
 
 
100 Lakeside Drive, Suite 100, Horsham,
Pennsylvania
       19044
 
 
(Address of Principal Executive Offices)
(Zip Code)
 
 
 
Registrant's telephone number, including area code:   215-619-3600

Not Applicable
(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o      Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o      Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o      Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o      Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 
 
 

 

 
Item 1.01
 
Entry into a Material Definitive Agreement

 
On November 4, 2014, PhotoMedex, Inc. ("PHMD") and its subsidiaries Radiancy, Inc.; LCA-Vision, Inc.; PhotoMedex Technology, Inc.; and Lumiere, Inc. (collectively, the "Company"), entered into an Amended and Restated Forbearance Agreement (the "Amended Forbearance Agreement") with the lenders (the "Lenders") that are parties to the Credit Agreement dated May 12, 2014, and with JP Morgan Chase ("Chase"), as Administrative Agent for the Lenders.

Under the Credit Agreement, the Company obtained $85 million in senior secured credit facilities ("the Facilities"), which included a $10 million revolving credit facility and a $75 million four-year term loan. The Credit Agreement contained financial covenants, including a maximum leverage covenant and a minimum fixed charge covenant, which the Company is required to maintain; the targets for those covenants are determined quarterly based on a rolling average of the past four quarters of financial data.  As stated in the Amended Forbearance Agreement, the Company had failed to meet both financial covenants for the fiscal quarters ending prior to December 31, 2014 (collectively, the "Specified Events of Default") and consequently is in default of the Facilities. On August 4, 2014, the Company received a notice of default and a reservation of rights from Chase and engaged a third-party independent advisor to assist the Company in negotiating a longer term solution to the defaults. The parties had entered into an initial Forbearance Agreement (the “Initial Forbearance Agreement”) on August 25, 2014; information on that Initial Forbearance Agreement is available in the Form 8-K filed  by the Company on August 25, 2014.

Pursuant to the terms of the Amended Forbearance Agreement, the Lenders have agreed to forbear from exercising their rights and remedies with respect to the Specified Events of Default from August 25, 2014 until February 28, 2014, or earlier if an event of default occurs (the "Forbearance Period").  The Company agreed to make prepayments on the term loan of $937,500 each on November 1 and December 1, 2014, and on January 1 and February 1, 2015, which will be applied in direct order of maturity.  The Company also agreed that, on or before the second business day after certain dates set forth in the Amended Forbearance Agreement, the Company would pay against the revolving loans an amount equal to 75% of cash-on-hand that exceeded $18 million.  In addition, the Company will make a payment of $1.5 million toward the revolving loans on or before February 16, 2015.  The interest rates on the Loans under the Credit Agreement will increase beginning November 1, 2014 to the CB Floating Rate plus 4.00%; an additional 2% will be added to that rate upon the occurrence and continuance of any default or event of default (other than a specified event of default).

The Company has retained the services of both Getzler Henrich, a third-party independent business advisor, as well as Canaccord Genuity, a banking and financial services company.  During the Forbearance Agreement, the Company and these advisors will prepare and distribute offering memoranda and other marketing materials to prospective lenders with regard to a proposed credit facility for the Company, the proceeds of which would be in an amount sufficient to repay in full and in cash the Company’s obligations under the Credit Agreement.  The closing of such a Refinancing would occur no later than the end of the Forbearance Period.

The Company agreed to limit certain capital expenditures to $552,000, except for those involving the Company's XTRAC® or VTRAC® medical devices, and will not make investments or acquire any other interests in affiliated companies except as agreed to by the Lenders.  The Company also agreed to execute certain documents pledging 64,896 shares of Radiancy (Israel) Ltd. and 13,000 shares of PhotoMedex Korea Ltd., as well as a Subordination Agreement in favor of the Administrative Agent and the Lenders with respect to the Company’s secured loan to its subsidiary, PhotoMedex Technology, Inc.

The Amended Forbearance Agreement is also subject to customary covenants, including limitations on the incurrence of or payments on indebtedness to other persons or entities and requirements that the Company provide periodic financial information and information regarding the status of outstanding litigation involving the Company and its subsidiaries to the Lenders.

 
 
-2-

 
 
 
If, by the end of the Forbearance Period, the Company and its Lenders have not entered into another forbearance agreement or otherwise reached an agreement regarding the Credit Agreement and the Facilities, the Lenders have the right to declare all of the obligations under the Credit Agreement and Facilities due and payable, including principal and interest, as authorized by the Credit Agreement, and to enforce additional obligations under the Amended Forbearance Agreement. Such a result would have a material adverse effect on the Company and its financial condition.

As consideration for the Lender's entry into the Forbearance Agreement, the Company paid the Lender a fee of $195,937.50.
 
The foregoing description of the Amended Forbearance Agreement does not purport to be complete and is qualified in its entirety by reference to the Amended Forbearance Agreement filed as Exhibit 10.1 to this Current Report on Form 8-K and incorporated herein by reference.

Cautionary Note Regarding Forward-Looking Statements

This Current Report on Form 8-K contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are subject to the “safe harbor” created by those sections. Forward-looking statements are based on our management’s beliefs and assumptions and on information currently available to our management. In some cases, you can identify forward-looking statements by terms such as “may,” “will,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “project,” “predict,” “intend,” “potential” and similar expressions intended to identify forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance, time frames or achievements to be materially different from any future results, performance, time frames or achievements expressed or implied by the forward-looking statements. We discuss many of these risks, uncertainties and other factors in our Annual Report on Form 10-K for the year ended December 31, 2013, and in our Quarterly Report on Form 10-Q for the quarters ended March 31, 2014, June 30, 2014 and September 30, 2014 under the heading “Risk Factors” in each of those reports. Given these risks, uncertainties and other factors, you should not place undue reliance on these forward-looking statements. Also, these forward-looking statements represent our estimates and assumptions only as of the date of this filing. You should read this Current Report on Form 8-K completely and with the understanding that our actual future results may be materially different from what we expect. We hereby qualify our forward-looking statements by our cautionary statements. Except as required by law, we assume no obligation to update these forward-looking statements publicly, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. 
 

ITEM 8.01
 
Other Events

On November 4, 2014, PhotoMedex, Inc. (the “Company”) issued a press release entitled “PHOTOMEDEX AGREES TO AMENDED FORBEARANCE AGREEMENT WITH SECURED CREDITORS, ENGAGES CANACCORD GENUITY TO EVALUATE STRATEGIC ALTERNATIVES”, announcing the Company has entered into an Amended and Restated Forbearance Agreement (the “Amended Forbearance Agreement”) with respect to its Credit Agreement dated May 12, 2014 and the Initial Forbearance Agreement dated August 25, 2014 by and among PhotoMedex, Inc. as borrower and the Lenders as parties thereto, and JPMorgan Chase Bank, N.A. (the “Administrative Agent”), acting on behalf of secured creditors as the administrative agent.


ITEM 9.01
 
Financial Statements and Exhibits

(d)            Exhibits.

10.1           Amended and Restated Forbearance Agreement dated November 4, 2014
 
99.1           Press Release dated November 4, 2014 issued by PhotoMedex, Inc.
 
 
 
 
-3-

 
 
 
SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this current report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
  PHOTOMEDEX, INC.  
       
Date: November 4, 2014
By:
/s/ Dolev Rafaeli  
    Dolev Rafaeli  
    Chief Executive Officer  
 
 

 
-4-

 

 
 
EXHIBIT INDEX

Exhibit No.
Description of Exhibit
10.1
Amended and Restated Forbearance Agreement dated November 4, 2014
   
99.1
Press Release dated November 4, 2014 issued by PhotoMedex, Inc.
 
 
 

 
-5-
EX-10.1 2 a50976663ex10_1.htm PHOTOMEDEX, INC. 10.1 a50976663ex10_1.htm
EXHIBIT 10.1
 

EXECUTION VERSION
 

 
AMENDED AND RESTATED FORBEARANCE AGREEMENT
 
AMENDED AND RESTATED FORBEARANCE AGREEMENT, dated as of October 31, 2014 (this “Forbearance”), with respect to that certain Credit Agreement, dated as of May 12, 2014 (as amended, supplemented or otherwise modified, the “Credit Agreement”), by and among PhotoMedex, Inc., as borrower (the “Borrower”), the Loan Parties from time to time party thereto, the Lenders from time to time party thereto, and JPMorgan Chase Bank, N.A., as administrative agent (the “Administrative Agent”), among others.
 
W I T N E S S E T H :
 
WHEREAS, the pursuant to the Credit Agreement, the Lenders have made Loans and other extensions of credit to the Borrower which remain outstanding;
 
WHEREAS, one or more Events of Default have occurred and are continuing;
 
WHEREAS, the Borrower, the Loan Parties party thereto, the Lenders and the Administrative Agent are parties to that certain Forbearance Agreement, dated as of August 25, 2014 (the “Initial Forbearance”), with respect to certain Specified Events of Default (as defined therein);
 
WHEREAS, the Borrower has requested that the Administrative Agent and the Lenders amend and restate the Initial Forbearance to further forbear beyond the October 31, 2014 expiration date of the Initial Forbearance from taking certain remedial actions under the Credit Agreement and the other Loan Documents with respect to the Specified Events of Default (as defined below); and
 
WHEREAS, the Administrative Agent and the Lenders are willing to do so, but only on the terms and conditions set forth herein;
 
NOW, THEREFORE, in consideration of the premises and for other good and valuable consideration the receipt and sufficiency of which is hereby acknowledged, the parties hereto hereby agree that the Initial Forbearance shall be amended and restated as follows:
 
ARTICLE I
DEFINITIONS
 
Section 1.1   Defined Terms.  Unless otherwise defined herein, capitalized terms used herein have the meanings assigned in the Credit Agreement, and the other Loan Documents, and the following terms shall have the following meanings:
 
 
 

 
 
Cash Flow Forecast” is defined in Section 4.1(b).
 
Cash on Hand” shall mean, as of any Business Day, the greater of (a) the average aggregate daily book balance of all monies on deposit in all accounts maintained at all financial institutions by the Loan Parties and their Subsidiaries during the five (5) prior Business Days, and (b) the aggregate daily book balance of all monies on deposit in all accounts maintained at all financial institutions by the Loan Parties and their Subsidiaries on such Business Day.
 
Consultant” shall mean Getzler Henrich & Assoc. LLC.
 
“Effective Date” shall mean the date hereof, but only upon satisfaction or waiver of the conditions precedent specified in Article V of this Forbearance.
 
Expiration Date” shall mean February 28, 2015.
 
“Forbearance Fee” is defined in Section 4.10.
 
“Forbearance Period” shall mean the period beginning on August 25, 2014 and ending on the earlier of (a) the Expiration Date or (b) the Termination Date.
 
Investment Banker” shall mean Canaccord Genuity, Inc., or another investment banking firm reasonably acceptable to the Administrative Agent and the Lenders.
 
Refinancing” is defined in Section 4.7(b).
 
Specified Events of Default” shall mean (i) the Borrower’s failure to maintain a Leverage Ratio for any fiscal quarter ending on or prior to December 31, 2014, of less than 2.50 to 1.00 in accordance with Section 6.11(a) of the Credit Agreement, and (ii) the Borrower’s failure to maintain a Fixed Charge Coverage Ratio for the trailing 12 months ending on any date on or prior to December 31, 2014, of more than 1.25 to 1.00 in accordance with Section 6.11(b) of the Credit Agreement.
 
“Termination Date” shall mean the date on which any event identified in Article III of this Forbearance shall occur.
 
ARTICLE II
FORBEARANCE
 
Section 2.1 .  Forbearance.  (a)   Subject to the terms and conditions hereof, the Administrative Agent and the Required Lenders hereby agree to forbear, during the Forbearance Period, from the exercise of any and all rights or remedies they may have with respect to, and only with respect to, the Loan Parties under the Credit Agreement, the other Loan Documents and applicable law, solely in respect of the Specified Events of Default.
 
(b)  For the avoidance of doubt, the agreements of the Administrative Agent and the Required Lenders in this Article II shall not apply to any Defaults or Events of Default other than the Specified Events of Default.  The Borrower further acknowledges and agrees that it shall not be permitted to request any Borrowings or other extensions of credit so long as any Default or Event of Default (including the Specified Events of Default) shall continue.
 
 
 

 
 
ARTICLE III
EVENTS OF TERMINATION
 
Section 3.1   Upon the occurrence of any of the following events:
 
(a)           any Loan Party shall default in the observance of any agreement contained in this Forbearance; or
 
(b)           the occurrence of a Default or Event of Default (other than a Specified Event of Default);
 
then, and in any such event, the provisions of Article II of this Forbearance shall immediately and automatically terminate and thereafter such Article shall have no force or effect.
 
ARTICLE IV
AGREEMENTS
 
Section 4.1   Reporting.  (a)  The Borrower shall furnish, or cause to be furnished, to the Administrative Agent on behalf of the Lenders, on Thursday of each week, a thirteen week rolling cash flow forecast which shall detail all sources and uses of cash on a weekly basis and shall report any variances from the prior report, and which, to the extent necessary, shall be reforecast in its entirety as of the end of each month (including a variance analysis with respect to such reforecast).  Each thirteen week rolling cash flow forecast shall be in form and substance satisfactory to the Administrative Agent and the Required Lenders (a “Cash Flow Forecast”).
 
(b)  Within thirty (30) days after the end of each calendar month, the Borrower shall furnish, or cause to be furnished, to the Administrative Agent on behalf of the Lenders the management’s internal financial statements, which shall have been reviewed by the Consultant (and incorporate the reasonable comments of the Consultant) and shall include its consolidated balance sheet and related statements of operations, stockholders’ equity and cash flows as of the end of and for such calendar month and the then elapsed portion of such fiscal year, setting forth in each case in comparative form the figures for (i) such period or periods as previously forecasted by the Borrower and (ii) the corresponding period or periods of (or, in the case of the balance sheet, as of the end of) the previous fiscal year.
 
(c)  Within thirty (30) days after the end of each calendar month, the Borrower shall furnish, or cause to be furnished, to the Administrative Agent and each Lender a status report on all actions, suits or proceedings by or before any arbitrator or Governmental Authority pending against or, to the knowledge of any Loan Party, threatened against or affecting any Loan Party or any Subsidiary, including, without limitation, all actions, suits or proceedings pending before the Israel District Court for Tel Aviv and the U.S. District Court for the Eastern District of Pennsylvania.  Each status report shall be in form and substance satisfactory to the Administrative Agent and the Required Lenders.
 
Section 4.2   Retention of Consultant.  (a)  The Borrower has retained the Consultant pursuant to an engagement letter that has been delivered to the Administrative Agent the Lenders and Borrower shall continue the retention of the Consultant at all times during the Forbearance Period.  The Borrower agrees that the Administrative Agent and the Lenders shall have continuous, direct access to the Consultant and shall promptly receive all non-privileged reports and other work product prepared by Consultant for the Borrower and/or its Subsidiaries from time to time.
 
 
 

 
 
(b)  The Borrower shall reasonably cooperate in all respects with any financial advisor that may after the Effective Date be retained by the Administrative Agent in its sole discretion and shall promptly (but no later than seven days after the delivery of any invoice) pay or reimburse the Administrative Agent for all reasonable and documented fees and out-of-pocket expenses incurred in connection therewith, including any retainer that may be required.
 
Section 4.3   Further Agreements.  (a)  Notwithstanding Section 6.01 of the Credit Agreement, during the Forbearance Period, the Loan Parties and their Subsidiaries shall not incur, or commit to incur, Indebtedness, other than Indebtedness permitted under Sections 6.01(a), (b), (c), (e) (to the extent that such Indebtedness under clause (e) does not exceed $250,000), (f), (g), (h), (k), (l), (m) and (p) of the Credit Agreement.
 
(b)  Notwithstanding Section 6.04 of the Credit Agreement, during the Forbearance Period, the Loan Parties and their Subsidiaries shall not make, or commit to make, Capital Expenditures in excess of $552,000 (not including the purchase of, or the classification as Capital Expenditures of, any XTRAC or VTRAC equipment) in the aggregate.
 
 (c)  Notwithstanding Sections 6.04 and 6.09 of the Credit Agreement, during the Forbearance Period, no Loan Party shall, nor shall any Loan Party permit any Subsidiary to, make any investment or any other interest in any Affiliate, other than investments set forth in the then-current Cash Flow Forecast in a party that is or becomes a Loan Party prior to the making of such investment and any other investments agreed to by the Administrative Agent and the Required Lenders.
 
(d)  Notwithstanding Section 6.07 of the Credit Agreement, during the Forbearance Period, no Loan Party shall, nor shall any Loan Party permit any Subsidiary to, enter into any Swap Agreement.
 
(e)  Notwithstanding Section 6.08 of the Credit Agreement, during the Forbearance Period, the Loan Parties and their Subsidiaries shall not declare, pay or make any dividend or distribution on any shares of capital stock or other interests.
 
(f)  Notwithstanding Section 2.06 of the Credit Agreement, during the Forbearance Period, (i) no outstanding Borrowing may be converted to or continued as a Eurodollar Borrowing and (ii) unless repaid, each Eurodollar Borrowing shall be converted to a CBFR Borrowing at the end of the Interest Period applicable thereto.
 
Section 4.4   Deliverables.  (a) The Borrower shall deliver to the Administrative Agent on behalf of the Lenders, promptly after the Borrower’s receipt thereof, a copy of the weekly media efficiency report for the prior week prepared by the Borrower’s outside consulting firm.
 
(b)  On or before November 5, 2014, the Borrower shall deliver to the Administrative Agent on behalf of the Lenders (i) a fully executed Share Transfer Deed with respect to 64,896 shares of Radiancy (Israel) Ltd., and (ii) a fully executed Pledge Supplement with respect to 13,000 shares of PhotoMedex Korea Ltd., together with an appropriate stock power, in each case, in form and substance satisfactory to the Administrative Agent.
 
(c)  On or before November 21, 2014, the Borrower shall deliver to the Administrative Agent on behalf of the Lenders a fully executed Subordination Agreement in favor of the Administrative Agent and the Lenders with respect to the Borrower’s secured loan to PhotoMedex Technology, Inc., and which agreement shall be in form and substance satisfactory to the Administrative Agent.
 
 
 

 
 
Section 4.5   Available Cash.  The Borrower shall not permit Cash on Hand as of the dates set forth on Schedule 1 attached hereto to be less than the amount set forth opposite such dates on such schedule.   On or before the second Business Day after the end of each calendar month, the Borrower shall deliver to the Administrative Agent a certificate of a Financial Officer certifying as to Cash on Hand, (a) for the remainder of 2014, as of the date in such month set forth on Schedule 1, and (b) for 2015, as of the last day of such prior month, in each case, in detail reasonably acceptable to the Administrative Agent.
 
Section 4.6   Interest.  Notwithstanding anything to the contrary contained in any of the Loan Documents, all Loans shall, beginning November 1, 2014, bear interest at the CB Floating Rate plus 4.00%.  Following the occurrence and continuance of any Default or Event of Default (other than a Specified Event of Default), the Obligations shall, at the option of the Lenders, bear interest at the rate of 2.00% plus the rate otherwise in effect.
 
Section 4.7   Investment Banker; Related Activities.  (a)  The Borrower shall at all times during the Forbearance Period continue the retention of the Investment Banker on terms reasonably acceptable to the Administrative Agent and the Lenders.  The Borrower agrees that the Administrative Agent and the Lenders shall have continuous, direct access to the Investment Banker and shall promptly receive all non-privileged reports and other work product prepared by Investment Banker for the Borrower and/or its Subsidiaries from time to time.  The Borrower shall, at the request of the Administrative Agent, cause the Investment Banker to participate on regular update calls with the Administrative Agent and the Lenders.
 
(b)  On or before November 24, 2014, the Investment Banker shall have distributed offering memoranda and other marketing materials to prospective lenders (and the Borrower shall concurrently deliver copies of such materials to the Administrative Agent and the Lenders) with regard to a proposed credit facility for the Borrower and its Subsidiaries, the proceeds of which would be in an amount sufficient to repay in full in cash all of the Obligations (a “Refinancing”).   The materials shall provide for a closing of the Refinancing not later than the Expiration Date, and shall otherwise be in form and substance reasonably satisfactory to the Administrative Agent.
 
(c)  On or before December 17, 2014, the Borrower shall deliver to the Administrative Agent and the Lenders one or more “indications of interest” from a bona fide third party with respect to a Refinancing, which indications shall be in form and substance reasonably satisfactory to the Administrative Agent.  The Borrower shall deliver all such “indications of interest” to the Administrative Agent and the Lenders promptly upon its receipt thereof.
 
(d)  On or before January 23, 2015, the Borrower shall deliver to the Administrative Agent one or more commitment letters from a bona fide third party or parties with respect to a Refinancing (each a “Commitment Letter”).   A Commitment Letter shall provide for a closing on or before the Expiration Date, shall not be subject to due diligence or financing contingency, and shall otherwise be in form and substance reasonably satisfactory to the Administrative Agent; provided, however, that notwithstanding the foregoing, any such Commitment Letter may be conditioned upon such third party’s reasonable confirmation with the Borrower’s outside auditors of Borrower’s financial results for the fourth quarter of its 2014 fiscal year.  The Borrower shall deliver all such Commitment Letters to the Administrative Agent and the Lenders promptly upon its receipt thereof.
 
Section 4.8   Prepayments.   (a)  The Borrower shall prepay the Term Loans as follows:  (i) on November 1, 2014, $937,500, (ii) on December 1, 2014, $937,500, (iii) on January 1, 2015, $937,500, and (iv) on February 1, 2015, $937,500, in each case, which shall be applied to the Term Loan in direct order of maturity.
 
 
 

 
 
 (b)   On or before the second Business Day after each of the dates set forth on Schedule 1, to the extent that Cash on Hand was in excess of $18 million as on such date, the Borrower shall repay the Revolving Loans in an amount equal to 75% of such excess.
 
  (c)   On or before February 16, 2015, the Borrower shall repay the Revolving Loans in an amount equal to $1,500,000.
 
Section 4.9   Mortgage.  On or before November 30, 2014, the Borrower shall deliver to the Administrative Agent (i) a fully executed and notarized senior mortgage encumbering the fee interest of LCA-Vision Inc. in the real property located at 7840 Montgomery Road, Cincinnati, Ohio, (ii) a mortgagee title insurance policy with respect thereto issued by a title insurance company reasonably acceptable to the Administrative Agent, and (iii) such other documents that are customary in connection with the delivery of a mortgage (including, without limitation a survey and legal opinion) and are reasonably requested by the Administrative Agent, in each case, in form and substance satisfactory to the Administrative Agent and the Lenders.
 
Section 4.10   Forbearance Fee.  The Borrower agrees to pay the Administrative Agent, for the pro rata account of the Lenders, a forbearance fee (the “Forbearance Fee”) as follows:  (a) an aggregate amount equal to 0.25% of the Principal Indebtedness (as defined below) outstanding immediately prior to the Effective Date which shall be payable to the Administrative Agent, for the pro rata account of those Lenders that execute this Forbearance on the Effective Date; and (b) an amount equal to $500,000 which shall be earned in full on the Effective Date and payable to the Administrative Agent, for the pro rata account of the Lenders, on the Expiration Date; provided, however, that the amounts in clause (b) shall be waived by the Administrative Agent and the Lenders upon payment in full in cash of the Obligations on or before the Expiration Date.
 
Section 4.11   Forbearance Agreements Deemed Agreements Under the Credit Agreement.  For purposes of the Credit Agreement, the agreements of the Loan Parties contained in this Forbearance shall be deemed to be, and shall be, agreements under the Credit Agreement.  Any breach on the part of the Loan Parties in respect of any agreement contained in this Forbearance shall constitute an Event of Default.
 
ARTICLE V
CONDITIONS PRECEDENT
 
This Forbearance shall not become effective unless and until each of the conditions precedent set forth below has been satisfied or the satisfaction thereof shall have been waived in accordance with the terms hereof:
 
(a)           Receipt by the Administrative Agent of counterparts of this Forbearance, duly executed and delivered by the Administrative Agent, the Required Lenders and the Loan Parties;
 
(b)           Receipt by the Administrative Agent of payment in full in cash of its invoiced and unpaid reasonable and documented fees and out-of-pocket expenses incurred in connection with the Credit Agreement or the other Loan Documents (which shall be deemed to include this Forbearance), including, without limitation, the reasonable fees and disbursements of the Administrative Agent’s counsel and advisors; and
 
 
 

 
 
(c)           Receipt by the Administrative Agent of that portion of the Forbearance Fee that is due and payable on the Effective Date.
 
ARTICLE VI
 
INTERPRETATION
 
Section 6.1   Continuing Effect of the Credit Agreement.  The Loan Parties, the Administrative Agent and the Lenders hereby acknowledge and agree that the Credit Agreement shall continue to be and remain unchanged and in full force and effect in accordance with its terms, except as expressly provided herein.
 
Section 6.2   No Limitation on Remedies after Forbearance Period.  The Loan Parties hereby acknowledge and agree that, at the end of the Forbearance Period, the provisions of Article II of the Forbearance shall be of no force and effect and the Administrative Agent and the Lenders shall be free, in accordance with the Credit Agreement and the other Loan Documents, to declare the Loans and all other amounts outstanding under the Credit Agreement to be due and payable and to exercise and enforce, or to take steps to exercise and enforce, all other rights, powers, privileges and remedies available to them under the Credit Agreement, any other Loan Document or applicable law on account of the Specified Events of Default (or any other Default or Event of Default that has occurred and is continuing) as if this Forbearance had not been entered into by the parties hereto.
 
Section 6.3   No Waiver; Other Defaults or Events of Default.  (a)  Nothing contained in this Forbearance shall be construed or interpreted or is intended as a waiver of any rights, powers, privileges or remedies that the Administrative Agent or the Lenders have or may have under the Credit Agreement or any other Loan Document on account of the Specified Events of Default, except as expressly provided herein.
 
(b) Nothing contained in this Forbearance shall be construed or interpreted or is intended as a waiver of or limitation on any rights, powers, privileges or remedies that the Administrative Agent or the Lenders have or may have under the Credit Agreement or any other Loan Document on account of any Default or Event of Default other than the Specified Events of Default.
 
ARTICLE VII
MISCELLANEOUS
 
Section 7.1   Representations and Warranties.  The Loan Parties hereby represent and warrant as of the date hereof that, after giving effect to this Forbearance, (a) no Default or Event of Default has occurred and is continuing, except the Specified Events of Default and (b) all representations and warranties of the Loan Parties contained in the Loan Documents (which shall be deemed to include this Forbearance) are true and correct in all material respects with the same effect as if made on and as of such date, except that Section 3.07 of the Credit Agreement shall be deemed to exclude any Specified Events of Default.
 
Section 7.2   Payment of Fees and Expenses.  The Borrower agrees to pay or reimburse the Administrative Agent upon demand, for all its reasonable and documented out-of-pocket costs and expenses incurred in connection with the Credit Agreement or the other Loan Documents (which shall be deemed to include this Forbearance), including, without limitation, the reasonable fees and disbursements of the Administrative Agent’s counsel and advisors.
 
 
 

 
 
Section 7.3   Confirmation of Indebtedness.  The Loan Parties hereby confirm and acknowledge that, as of the date hereof, (i) the Borrower is truly and justly indebted to the Lenders, without defense, counterclaim or offset of any kind, (ii) the Borrower is liable to the Lenders in respect of Loans made under the Credit Agreement in the aggregate principal amount of $78,375,000.00 (exclusive of Letters of Credit) (the “Principal Indebtedness”) and (iii) each Guarantor is contingently liable to the Lenders in respect of such amount.
 
Section 7.4   Counterparts.  This Forbearance may be executed by the parties hereto in any number of separate counterparts, and all of said counterparts taken together shall be deemed to constitute one and the same instrument.
 
Section 7.5   GOVERNING LAW.  THIS FORBEARANCE AND THE RIGHTS AND OBLIGATIONS OF THE PARTIES UNDER THIS FORBEARANCE SHALL BE GOVERNED BY, AND CONSTRUED AND INTERPRETED IN ACCORDANCE WITH, THE LAW OF THE STATE OF NEW YORK.
 
Section 7.6   Reservation of Rights.  Notwithstanding anything contained in this Forbearance to the contrary, the Loan Parties acknowledge that the Administrative Agent and the Lenders do not waive, and expressly reserve, the right to exercise, at any time during the Forbearance Period, any and all of their rights and remedies under (a) the Credit Agreement, any other Loan Document and applicable law in respect of the Specified Events of Default against any Person other than any Loan Party and (b) the Credit Agreement, any other Loan Document and applicable law in respect of any Default or Event of Default other than the Specified Events of Default.
 
Section 7.7   Consent of Guarantors.  Each Guarantor hereby (a) consents to the transactions contemplated hereby and (b) acknowledges and agrees that the guarantees (and all security therefore) contained in the Credit Agreement and the other Loan Documents previously executed by it are, and shall remain, in full force and effect after giving effect to this Forbearance and all other prior modifications to the Credit Agreement.
 
Section 7.8   Release.  The Loan Parties, on behalf of themselves and successors-in-title, legal representatives and assignees and, to the extent the same is claimed by right of, through or under any of the Loan Parties, for its past, present and future employees, agents, representatives, officers, directors, shareholders, and trustees (each, a “Releasing Party” and collectively, the “Releasing Parties”) hereby release, waive, and forever relinquish all claims, demands, obligations, liabilities and causes of action of whatever kind or nature (including, without limitation, any so-called “lender liability” claims, interest or other carrying costs, penalties, legal, accounting and other professional fees and expenses and incidental, consequential and punitive damages payable to third parties, or any claims arising under 11 U.S.C. §§ 541-550 or any claims for avoidance or recovery under any other federal, state or foreign law equivalent), whether known or unknown, which any of the Releasing Parties have, may have, or might assert at the time of execution of this Forbearance against the Administrative Agent, the Lenders and/or their respective parents, affiliates, participants, officers, directors, employees, agents, attorneys, accountants, consultants, successors and assigns, directly or indirectly, which occurred, existed, was taken, permitted or begun prior to the execution of this Forbearance, arising out of, based upon, or in any manner connected with (i) any transaction, event, circumstance, action, failure to act or occurrence of any sort or type, whether known or unknown, with respect to the Credit Agreement, any other Loan Document and/or the administration thereof or the Obligations created thereby; (ii) any discussions, commitments, negotiations, conversations or communications with respect to the refinancing, restructuring or collection of any Obligations related to the Credit Agreement, any other Loan Document and/or the administration thereof or the Obligations created thereby, or (iii) any matter related to the foregoing, in each case, prior to the execution of this Forbearance.
 
 
 

 
 
IN WITNESS WHEREOF, the parties hereto have caused this Forbearance to be duly executed and delivered by their proper and duly authorized officers as of the date first above written.
 
 
 
PHOTOMEDEX, INC.,
a Nevada corporation
   
 
By:  /s/ Dennis M. McGrath                                  
Name:  Dennis M. McGrath
Title:  President and Chief Financial Officer
   
 
LCA-VISION INC.,
a Delaware corporation
   
 
By:  /s/ Dennis M. McGrath                                  
Name:  Dennis M. McGrath
Title:  President
   
 
RADIANCY, INC.,
a Delaware corporation
   
 
By/s/ Dolev Rafaeli                  
Name:  Dolev Rafaeli
Title:  President and Chief Executive Officer
   
 
PHOTOMEDEX TECHNOLOGY, INC.,
a Delaware corporation
   
 
By:  /s/ Dennis M. McGrath                                  
Name:  Dennis M. McGrath
Title:   President
   
 
LUMIERE, INC.,
a Nevada corporation
   
 
By:  /s/ Dennis M. McGrath                                  
Name:  Dennis M. McGrath
Title:   President
 
 
 

 
 
 
   
 
JPMORGAN CHASE BANK, N.A., as Administrative Agent and a Lender
   
 
By:  /s/ Lauren Daley
Name:  Lauren Daley
Title:  Authorized Officer
 
 
 

 
 
   
 
FIRST NIAGARA BANK, N.A., as a Lender
   
   By:  /s/ Gary P. Danis                              
Name: Gary P. Danis
Title: First Vice President
 
 
 

 
 
   
 
PNC BANK, N.A., as a Lender
   
 
By:  /s/ John Ataman                  
Name: John Ataman
Title:  Vice President
 
 
 

 
 
   
 
BANK LEUMI LE-ISRAEL B.M., as a Lender
   
 
By:  /s/ Tamar Dominitz                                                                
Name: Tamar Dominitz
Title: Customer Manager
   
 
By:/s/ Albert Yazgilov                                                                
Name: Albert Yazgilov
Title: Branch Manager
   
   
 
 
 

 
 
SCHEDULE 1
   
 DATE
Cash on Hand
 November 28, 2014
$  6,500,000
 January 2, 2015
$14,700,000
 January 31, 2015
$  9,100,000  
 February 28, 2015
$  7,600,000
 
EX-99.1 3 a50976663ex99_1.htm PHOTOMEDEX, INC. 99.1 a50976663ex99_1.htm
Exhibit 99.1
 
PHOTOMEDEX AGREES TO AMENDED FORBEARANCE AGREEMENT WITH SECURED CREDITORS, ENGAGES CANACCORD GENUITY TO EVALUATE STRATEGIC ALTERNATIVES
 
HORSHAM, Pa.--(BUSINESS WIRE)--November 4, 2014--PhotoMedex, Inc. (NasdaqGS and TASE: PHMD) announces the Company has entered into an Amended and Restated Forbearance Agreement (the "Amended Forbearance Agreement") with respect to its Credit Agreement dated May 12, 2014 and the Initial Forbearance Agreement dated August 25, 2014 by and among PhotoMedex, Inc. as borrower and the Lenders as parties thereto, and JPMorgan Chase Bank, N.A. (the "Administrative Agent"), acting on behalf of secured creditors as the administrative agent.
 
Subject to the terms of the Amended Forbearance Agreement, for a period until February 28, 2015 (the "Forbearance Period"), the Administrative Agent will forbear from exercising any remedies relating to specified defaults by the Company under the Credit Agreement. During the Forbearance Period, the Company has agreed to abide by certain additional reporting requirements, restrictions on certain affiliate transfers, retention of an investment bank to pursue options in connection with refinancing the Company's secured debt as well as other terms and conditions detailed in a Form 8-K filed with the SEC.
 
The Company also announces it has retained Canaccord Genuity Inc. to evaluate strategic alternatives with the objective of enhancing stakeholder value, including assisting the Company in the refinancing of its debt. The Board of Directors intends to consider the full range of available options.  There can be no assurance that any specific transaction will be pursued or completed. There are certain milestone obligations contained in the Amended Forbearance Agreement in connection with the process of obtaining a new credit facility.  The Company does not intend to disclose developments with respect to those milestone obligations or the progress of its strategic alternatives review process until such time as the Board of Directors approves, or the Company completes, one or more transactions or otherwise deems further disclosure appropriate.
 
About Canaccord Genuity Inc.

Canaccord Genuity Inc. is the global capital markets division of Canaccord Genuity Group Inc. (TSX: CF, LSE: CF.), offering institutional and corporate clients idea-driven investment banking, merger and acquisition, research, sales and trading services from offices in 10 countries worldwide. Our team of nearly 1,000 capital markets and advisory professionals has industry and transactional expertise in 18 key sectors of the global economy. We are committed to providing valued services to our clients throughout the entire lifecycle of their business and operating as a gold standard independent investment bank – expansive in resources and reach, but targeted in industry expertise, market focus and individual client attention.

More information is available at www.canaccordgenuity.com.

About PhotoMedex

PhotoMedex, Inc. is a Global Health products and services company providing integrated disease management and aesthetic solutions to dermatologists, professional aestheticians, ophthalmologists, optometrists, consumers and patients. The Company provides proprietary products and services that address skin conditions including psoriasis, vitiligo, acne, actinic keratosis, photo damage and unwanted hair, as well as fixed-site laser vision correction services at our LasikPlus® vision centers. Its experience in the physician market provides the platform to expand its skin health solutions to spa markets, as well as traditional retail, online and infomercial outlets for home-use products. PhotoMedex sells home-use devices under the no!no!™ brand for various indications including hair removal, acne treatment and skin rejuvenation. The company also offers a professional product line for acne clearance, skin tightening, psoriasis care and hair removal sold to physician clinics and spas. PhotoMedex further expanded its base through the acquisition of LCA-Vision Inc., a leading provider of laser vision correction services under the LasikPlus® brand.  LCA-Vision operates 60 LasikPlus® vision centers in the U.S., including 51 full-service LasikPlus® fixed-site laser vision correction centers and nine pre- and post-operative LasikPlus® satellite centers. LCA-Vision has performed more than 1.3 million procedures since FDA approval of photorefractive keratectomy (PRK) in late 1995.
 
 

 
SAFE HARBOR STATEMENT

This press release contains forward looking statements, including, but not limited to statements relating to PhotoMedex’s future financial performance, strategies, potential sales and earnings growth. Some portions of this release, particularly those describing PhotoMedex' strategies, operating expense reductions and business plans will contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to risks, uncertainties and other factors.   All statements other than statements of historical fact are statements that could be deemed forward-looking statements, including any statements of the plans, strategies and objectives of management for future operations; any statements regarding product development, product extensions, product integration or product marketing; any statements regarding continued compliance with government regulations, changing legislation or regulatory environments; any statements of expectation or belief and any statements of assumptions underlying any of the foregoing. In addition, there are risks and uncertainties related to successfully integrating the products and employees of the Company and Radiancy, as well as the ability to ensure continued regulatory compliance, performance and/or market growth.  These risks, uncertainties and other factors, and the general risks associated with the businesses of the Company described in the reports and other documents filed with the SEC, could cause actual results to differ materially from those referred to, implied or expressed in the forward-looking statements.  The Company cautions readers not to rely on these forward-looking statements.  All forward-looking statements are based on information currently available to the Company and are qualified in their entirety by this cautionary statement.  The Company anticipates that subsequent events and developments will cause its views to change.  The information contained in this conference call speaks as of the date hereof and the Company has or undertakes no obligation to update or revise these forward-looking statements, whether as a result of new information, future events or otherwise.

Contacts

LHA
Kim Sutton Golodetz, 212-838-3777
Kgolodetz@lhai.com
or
Bruce Voss, 310-691-7100
Bvoss@lhai.com
or
PhotoMedex, Inc.
Dennis McGrath, 215-619-3287
Chief Financial Officer
info@photomedex.com